Pfizer-AstraZeneca bankers set to miss up to $340 million in fees

[riky]

Pfizer-AstraZeneca bankers set to miss up to $340 million in fees

By Sophie Sassard LONDON (Reuters) - Bankers advising pharmaceuticals companies Pfizer and Britain's AstraZeneca are likely to miss out on $260-340 million in fees after the U.S. company's final takeover bid was rejected on Monday. Pfizer's sweetened 70 billion pound ($118 billion) offer was dismissed by AstraZeneca as being too low and the U.S. group is expected to announce by Monday that it will now abandon its move to create the world's biggest drugs group. The U.S. company's advisers at JP Morgan , Bank of America Merrill Lynch and Guggenheim Securities are likely to be the biggest losers. A source familiar with the situation said Pfizer is unlikely to pay any fees if the deal is not consummated.

Source: You are not allowed to view links. Register or Login